- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05536869
Study Comparing a Cohort of Women Having a Classic Caesarean to a Cohort of Women Having a FAUCS Caesarean (FAUCS) (FAUCS)
September 13, 2022 updated by: Ramsay Générale de Santé
Prospective Multicenter Study Comparing a Cohort of Women Having a Classic Caesarean to a Cohort of Women Having a FAUCS Caesarean
The main objective of this study is to compare the time taken to obtain "street fitness" status for women after extraperitoneal cesarean section compared to women after a classic cesarean section.
Study Overview
Status
Recruiting
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
72
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
IDF
-
Versailles, IDF, France, 78000
- Recruiting
- Les Franciscaines Clinic
-
Contact:
- Bénédicte Simon
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 42 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Patient scheduled for a caesarean between 38 and 42 weeks pregnant
- Patient aged between 18 and 42 years old
- Singleton
- Caesarean section with a theoretical operating time < 1 hour (without major complications)
- Patient affiliated to a social security scheme
- Patient having signed the free and informed consent.
Exclusion Criteria:
- BMI > 40
- High blood pressure treated intravenously
- Pre-existing diabetes in pregnancy
- Allergy to analgesics
- Prenatal depression
- Pathological insertion of the placenta (placenta previa or accreta).
- History of major pelvic or abdominal surgery (myomectomy, peritonitis) other than caesarean section or minor surgery.
- Addiction (drugs)
- Pre-existing psychiatric pathology leading to a risk of impaired judgment or behavior.
- Patient participating in another clinical study with a drug or medical device
- Protected patient: Adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision
- Patient hospitalized without consent.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: Patient with intraperitoneal caesarean section
|
Two different caesarean section techniques : intra or extraperitoneal
|
|
EXPERIMENTAL: patient with extraperitoneal caesarean section
Faucs technique
|
Two different caesarean section techniques : intra or extraperitoneal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The postoperative time in hours from which the patient stably fulfills the criteria for "street fitness".
Time Frame: 1 month
|
These criteria are defined in the Chung score.
This score is between 0 and 10 and evaluate the vital signs, wandering, nausea or vomits, pain and surgical bleeding.
|
1 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
December 27, 2021
Primary Completion (ANTICIPATED)
September 27, 2022
Study Completion (ANTICIPATED)
July 27, 2023
Study Registration Dates
First Submitted
September 8, 2022
First Submitted That Met QC Criteria
September 8, 2022
First Posted (ACTUAL)
September 13, 2022
Study Record Updates
Last Update Posted (ACTUAL)
September 15, 2022
Last Update Submitted That Met QC Criteria
September 13, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- 2019-A01220-57
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cesarean Section; Dehiscence
-
Recep Tayyip Erdogan University Training and Research...CompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Aljazeera HospitalCompleted
-
Kocaeli UniversityCompletedCesarean Section; Dehiscence | Cesarean Wound; DehiscenceTurkey
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedCesarean Section Complications | Cesarean Section; DehiscenceTurkey
-
Ataturk UniversityCompletedCesarean Section; Dehiscence | First BirthTurkey
-
Safak Baran YilmazCompletedCesarean Section Complications | Cesarean Section; Dehiscence | Uterine ScarTurkey
-
HealthPlus Fertility CenterRecruitingCesarean Section; Dehiscence | Reproductive Issues | Intrauterine DisorderUnited Arab Emirates
-
T.C. ORDU ÜNİVERSİTESİCompletedBreast Feeding | Self Efficacy | Cesarean Section; DehiscenceTurkey
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...CompletedCesarean Section Complications | Cesarean Wound; DehiscenceItaly
-
Odense University HospitalHvidovre University Hospital; Smith & Nephew, Inc.; University of Southern Denmark and other collaboratorsCompletedSurgical Wound Infection | Cesarean Section; Dehiscence | Complications; Cesarean Section | Infection; Cesarean Section | Complications; Cesarean Section, Wound, Dehiscence | Wound; Rupture, Surgery, Cesarean SectionDenmark
Clinical Trials on Caesarean
-
Ain Shams UniversityRecruitingPelvic Congestion SyndromeEgypt
-
Aarhus University HospitalCompletedRespiratory Disorders | Intensive Care, NeonatalDenmark
-
Assistance Publique - Hôpitaux de ParisCompletedFecal IncontinenceFrance
-
Royal Infirmary of EdinburghUnknownChronic Pain | Cesarean Section ComplicationsUnited Kingdom
-
Darlington-Peter Chibuzor UgojiCompletedComplication | PostoperativeNigeria
-
University Tunis El ManarCompleted
-
Ain Shams UniversityCompletedAnteversion of Uterus | Retroflex Uterus | CSDEgypt
-
Cairo UniversityNot yet recruiting
-
University Tunis El ManarWithdrawn